<DOC>
	<DOCNO>NCT01846429</DOCNO>
	<brief_summary>The purpose study : - Determine well people tolerate sodium bicarbonate take mouth high dose usually give heartburn . - Determine sodium bicarbonate reduce cancer-related pain .</brief_summary>
	<brief_title>Oral Bicarbonate Adjuvant Pain Reduction Patients With Tumor Related Pain</brief_title>
	<detailed_description>Single institution Phase I/II study sodium bicarbonate combination standard medical management patient moderate severe tumor relate pain . Patients metastatic solid malignancy patient hematologic malignancy moderate severe tumor relate pain stable opioid regimen subject study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Patients must metastatic unresectable solid malignancy hematologic malignancy ( multiple myeloma lymphoma ) must moderate severe tumor relate pain visual assessment scale ( VAS ) &gt; 4 ) stable opioid regimen ( least 3 day opiate regimen ) . VAS score great 4 screen eligible . No planned palliative surgery , palliative radiotherapy least 4 week . However prior radiotherapy , surgery allow limited number procedure course . Concomitant chemotherapy agent indicate protocol guideline ( Tables 10 11B , Appendix IV ) allow . No evidence neurologic psychiatric compromise opinion investigator interfere completion study assessment Age great 18 year able understand sign inform consent document Patients must Eastern Cooperative Oncology Group ( ECOG ) performance status less 3 . A female patient male patient 's female partner , childbearing potential , must agree use 2 adequate barrier method contraception prevent pregnancy abstain heterosexual activity throughout study , start Visit 1 , receive protocolspecified medication , 1 month stop medication . Patients neuropathy and/or neuropathic pain pain syndrome eligible . Patients chronic nonmalignant pain eligible . Patients renal insufficiency ( creatinine &gt; 2.5mg/dL ) exclude . Patients history congestive heart failure pulmonary artery hypertension exclude . Patients uncontrolled hypertension ( systolic pressure &gt; 160 , diastolic pressure &gt; 100 ) despite maximal antihypertensive therapy Patients unable ingest sodium bicarbonate capsule ( patient dysphagia severe nausea ) Patients ECOG performance status 3 high Patients acute leukemia , myelodysplastic syndrome , chronic myeloid leukemia eligible . Pregnant lactate patient eligible . Patients know allergy sodium bicarbonate patient preexist renal acid base disorder sodium bicarbonate contraindicate ( metabolic alkalosis , severe congestive heart failure , hypernatremia , hypocalcemia ( see ) ) Patients severe ongoing infection place patient increase risk therapy opinion investigator Patients receive concomitant chemotherapy agent indicate protocol guideline ( Tables 10 11B , Appendix IV ) target therapy intend prolong life within 2 week start study drug Patients receive experimental therapy within 2 week start study treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>cancer</keyword>
	<keyword>pain fiber</keyword>
	<keyword>acid level</keyword>
	<keyword>tumor relate pain</keyword>
	<keyword>cancer relate pain</keyword>
	<keyword>sodium bicarbonate</keyword>
	<keyword>pain reliever</keyword>
	<keyword>metastatic</keyword>
	<keyword>unresectable</keyword>
	<keyword>solid malignancy</keyword>
	<keyword>hematologic malignancy</keyword>
	<keyword>multiple myeloma</keyword>
	<keyword>lymphoma</keyword>
</DOC>